SCHEMBL4763127

SCHEMBL4763127

C#CCC[CH]C#CCCCC

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 2/20 0.33
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19640288 0.82 HMGCR (0.43) HMGCRTSHR
SCHEMBL2933749 0.82 HMGCR (0.43) HMGCRTSHR
SCHEMBL6820171 0.81 HMGCR (0.33) HMGCRTSHR
SCHEMBL8893382 0.81 HMGCR (0.33) HMGCRTSHR
SCHEMBL5813803 0.80
SCHEMBL6852096 0.79
SCHEMBL8385155 0.77 HMGCR (0.44) HMGCRTSHR
SCHEMBL1533719 0.76 HMGCR (0.42) HMGCRTSHR
SCHEMBL3030008 0.74 HMGCR (0.49) HMGCRTSHR
SCHEMBL29012576 0.74 KDM4E (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1927594-A1 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia Arena Pharmaceuticals, Inc. (US) 2008-06-04 EP disclosed